Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Mission Produce
AVO
$1.11B
| $4.04M | ﹤0.01% |
257,516
+3,774
| +1% | +$70.2K |
|
2452
4D Molecular Therapeutics
FDMT
$532M
| $4.04M | ﹤0.01% |
184,299
+39,145
| +27% | +$959K |
|
2453
Franklin Covey
FC
$242M
| $4.04M | ﹤0.01% |
87,200
+1,899
| +2% | +$84.2K |
|
|
SQSP
2454
DELISTED
Squarespace, Inc.
SQSP
| $4.04M | ﹤0.01% |
136,838
+2,073
| +2% | +$75.1K |
|
2455
OneSpaWorld
OSW
$2.61B
| $4.03M | ﹤0.01% |
402,219
+19,679
| +5% | +$209K |
|
|
OLP
2456
One Liberty Properties
OLP
$530M
| $4M | ﹤0.01% |
113,388
+1,504
| +1% | +$49.8K |
|
2457
NRC Health Common Stock
NRC
$432M
| $4M | ﹤0.01% |
96,337
+818
| +0.9% | +$35.6K |
|
2458
Wheels Up
UP
$208M
| $4M | ﹤0.01% |
4,310
+56
| +1% | +$65.3K |
|
2459
Phibro Animal Health
PAHC
$1.47B
| $4M | ﹤0.01% |
195,730
+43,358
| +28% | +$926K |
|
|
THR
2460
DELISTED
Thermon Group Holdings
THR
| $3.99M | ﹤0.01% |
235,535
+6,686
| +3% | +$117K |
|
2461
Titan International
TWI
$466M
| $3.98M | ﹤0.01% |
362,628
+4,912
| +1% | +$38.5K |
|
2462
Workhorse Group
WKHS
$33.2M
| $3.97M | ﹤0.01% |
303
+52
| +21% | +$945K |
|
|
YMAB
2463
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.97M | ﹤0.01% |
244,744
+5,125
| +2% | +$110K |
|
|
BTRS
2464
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $3.97M | ﹤0.01% |
507,331
+21,383
| +4% | +$185K |
|
2465
Qfin Holdings
QFIN
$1.69B
| $3.97M | ﹤0.01% |
172,935
-3,208
| -2% | -$71.4K |
|
2466
Hims & Hers Health
HIMS
$6.43B
| $3.94M | ﹤0.01% |
601,224
+14,227
| +2% | +$103K |
|
|
REVG
2467
DELISTED
REV Group
REVG
| $3.94M | ﹤0.01% |
278,287
+54,495
| +24% | +$861K |
|
|
ALX
2468
Alexander's
ALX
$1.3B
| $3.92M | ﹤0.01% |
15,078
+196
| +1% | +$52.6K |
|
2469
Seres Therapeutics
MCRB
$46.8M
| $3.92M | ﹤0.01% |
23,515
+221
| +0.9% | +$35.1K |
|
2470
Turning Point Brands
TPB
$1.45B
| $3.92M | ﹤0.01% |
103,704
+2,907
| +3% | +$118K |
|
2471
RLX Technology
RLX
$2.47B
| $3.91M | ﹤0.01% |
1,002,500
+34,636
| +4% | +$160K |
|
|
KRON
2472
DELISTED
Kronos Bio
KRON
| $3.89M | ﹤0.01% |
286,158
+5,573
| +2% | +$87.2K |
|
2473
Arrow Financial
AROW
$659M
| $3.89M | ﹤0.01% |
117,037
+2,598
| +2% | +$87.6K |
|
|
TPIC
2474
DELISTED
TPI Composites
TPIC
| $3.88M | ﹤0.01% |
259,673
+2,337
| +0.9% | +$57.3K |
|
2475
Red Robin
RRGB
$145M
| $3.88M | ﹤0.01% |
234,765
+10,581
| +5% | +$202K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.